JMP Securities Initiates Coverage On Sana Biotechnology with Market Outperform Rating, Announces Price Target of $9
Portfolio Pulse from Benzinga Newsdesk
JMP Securities has initiated coverage on Sana Biotechnology (NASDAQ:SANA) with a Market Outperform rating and a price target of $9.
September 25, 2023 | 9:06 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sana Biotechnology's stock could see positive movement following JMP Securities' Market Outperform rating and $9 price target.
Analyst ratings often influence stock prices. JMP Securities' Market Outperform rating suggests they believe SANA's stock will outperform the market, which could lead to increased investor interest and a potential rise in stock price. The price target of $9 also indicates a positive outlook.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100